References
- Juhn SK, Jung MK, Hoffman MD. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol. 2008;1:117–138.
- Hirai H, Kariya S, Okano M, et al. Expression of toll-like receptors in chronic otitis media and cholesteatoma. Int J Pediatr Otorhinolaryngol. 2013;77:674–676.
- Jesic S, Jotic A, Tomanovic N, et al. Expression of toll-like receptors 2, 4 and nuclear factor kappa B in mucosal lesions of human otitis: pattern and relationship in a clinical immunohistochemical study. Ann Otol Rhinol Laryngol. 2014;123:434–441.
- Lee HY, Park MS, Byun JY, et al. Expression of pattern recognition receptors in cholesteatoma. Eur Arch Otorhinolaryngol. 2014;271:245–253.
- Kariya S, Okano M, Aoji K, et al. Role of macrophage migration inhibitory factor in otitis media with effusion in adults. Clin Diagn Lab Immunol. 2003;10:417–422.
- Strowig T, Henao-Mejia J, Elinav E, et al. Inflammasomes in health and disease. Nature. 2012;481:278–286.
- Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013–1022.
- Franchi L, Muñoz-Planillo R, Núñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol. 2012;13:325–332.
- Granath A, Cardell L-O, Uddman R, et al. Altered Toll- and Nod-like receptor expression in human middle ear mucosa from patients with chronic middle ear disease. J Infect. 2011;63:174–176.
- Kariya S, Okano M, Zhao P, et al. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media. Acta Otolaryngol. 2016;136:136–140.
- Kurabi A, Lee J, Wong C, et al. The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media. Innate Immun. 2015;21:203–214.
- Ford AH, Hankey GJ, Yeap BB, et al. Hearing loss and the risk of dementia in later life. Maturitas. 2018;112:1–11.
- Maeda Y, Takao S, Sugaya A, et al. Relationship between pure-tone audiogram findings and speech perception among older Japanese persons. Acta Otolaryngol. 2018;138:140–144.
- Martinon F, Burns K, Tschopp J. The inflammasome a molecular platform triggering activation of inflammatory caspases and processing of proIL-Beta. Mol Cell. 2002;10:417–426.
- Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017;277:61–75.
- Hughes MM, O'Neill LAJ. Metabolic regulation of NLRP3. Immunol Rev. 2018;281:88–98.
- Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281:8–27.
- Jo EK, Kim JK, Shin DM, et al. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148–159.